Matches in Nanopublications for { ?s ?p "[Our results may explain the ineffectiveness of some SSTR2 selective SRIH analogues in the treatment of prostate cancer and suggest that the absence of SSTR2 could represent a growth advantage in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_assertion description "[Our results may explain the ineffectiveness of some SSTR2 selective SRIH analogues in the treatment of prostate cancer and suggest that the absence of SSTR2 could represent a growth advantage in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_provenance.
- assertion description "[Our results may explain the ineffectiveness of some SSTR2 selective SRIH analogues in the treatment of prostate cancer and suggest that the absence of SSTR2 could represent a growth advantage in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our results may explain the ineffectiveness of some SSTR2 selective SRIH analogues in the treatment of prostate cancer and suggest that the absence of SSTR2 could represent a growth advantage in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP714404.RADPLDiMb_Ua6MPn1SdbPJPZZYh4ua7pXoKrUVYy01DCw130_assertion description "[Our results may explain the ineffectiveness of some SSTR2 selective SRIH analogues in the treatment of prostate cancer and suggest that the absence of SSTR2 could represent a growth advantage in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714404.RADPLDiMb_Ua6MPn1SdbPJPZZYh4ua7pXoKrUVYy01DCw130_provenance.
- NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_assertion description "[Our results may explain the ineffectiveness of some SSTR2 selective SRIH analogues in the treatment of prostate cancer and suggest that the absence of SSTR2 could represent a growth advantage in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1378285.RAkrpSf5fOtSJe1eKkYPPN_jK6dqqH5OaxLHZQgFdnOnY130_provenance.
- NP1378283.RAxbHfTJytaSkIP2CQmob6watRz5cveMmBfaFsX1AVN8Y130_assertion description "[Our results may explain the ineffectiveness of some SSTR2 selective SRIH analogues in the treatment of prostate cancer and suggest that the absence of SSTR2 could represent a growth advantage in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1378283.RAxbHfTJytaSkIP2CQmob6watRz5cveMmBfaFsX1AVN8Y130_provenance.